Skip to search formSkip to main contentSkip to account menu

CLEC12A gene

Known as: C-type lectin domain family 12 member A, C-TYPE LECTIN DOMAIN FAMILY 12, MEMBER A, MICL 
National Institutes of Health

Related topics

Related topics

1 relation
Lectins, C-Type

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Taking the MICL: An Interdisciplinary Masters Programme in Innovation, Creativity and Leadership
The Masters in Innovation, Creativity and Leadership (the MICL) is an innovative, radically interdisciplinary and highly… 
2016
2016
An anti-CD 3 / anti – CLL-1 bispeci fi c antibody for the treatment of acute myeloid leukemia
• Bispecific antibodies binding CD3 and CLL-1 deplete CLL-1 target cells in animal models. • An appropriately engineered CLL-1… 
2015
2015
The Plasma Level of Leukemia Stem Cell Specific Antigens - CLL1 and TIM3 Are Predictive of Overall Survival in Acute Myeloid Leukemia
Background: Despite intensive chemotherapy, acute myeloid leukemia (AML) is still associated with significant relapse rate. This… 
2015
2015
Antibody blocking of CLEC12A delays the course and attenuates EAE severity by impairing myeloid cell CNS infiltration: A potential new therapy for multiple sclerosis (CAM4P.158)
The mechanism of dendritic cell (DC) recruitment across the blood brain barrier during neuroinflammation has been the least… 
2014
2014
repressing synthesis of Lpp , the major outer membrane lipoprotein-dependent sRNA , combats envelope stress byE σ MicL , a new Material Supplemental
Material Supplemental http://genesdev.cshlp.org/content/suppl/2014/07/16/28.14.1620.DC1.html References http://genesdev.cshlp.org… 
2012
2012
Role of C-type lectin receptor CLEC12A in human basophil activation (48.6)
CLEC12A is a member of the C-type lectin receptor family with a cytoplasmic immunoreceptor tyrosine-based inhibitory motif… 
2011
2011
Gender classification based on lossy data coding
This paper concerns the gender classification task of discriminating between images of faces of men and women from face images… 
2010
2010
Targeting of CLEC12A In Acute Myeloid Leukemia by Antibody-Drug-Conjugates and Bispecific CLL-1×CD3 BiTE Antibody
Abstract 2890 Response rates of ±80% in Acute Myeloid Leukemia (AML) are observed after conventional therapy but ±30% of patients… 
2007
2007
CLL-1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia.
CLL-1 (C-type Lectin-Like Molecule-1) is an inhibitory receptor expressed on myeloid cells. We have generated a series of… 
1988
1988
Process-oriented model integration
The authors outline a process-oriented approach to model integration based on familiar notions from discrete-event simulation and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)